CBOE vs SRPT · P/E 24, rev $2.72B vs rev $1.13B
Cboe Global Markets Inc (CBOE) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CBOE and SRPT stock pages for the full models.
Not investment advice.